PHILADELPHIA, PA — Mick Cronin won the battle against Dan Hurley over who would receive a technical foul first. The UCLA men's basketball coach was assessed a technical foul at the 4:41 mark of the ...

Los Angeles Lakers star Luka Dončić will be back in action Monday night after the NBA rescinded his 16th technical foul of the season, initially handed down during Saturday night's 105-104 win over ...

The NBA has rescinded Luka Doncic's 16th technical foul, allowing him to play in the Los Angeles Lakers' road game against the Detroit Pistons on Monday night. He received the technical foul in ...

Immunic (IMUX) shares rose on Tuesday after Guggenheim launched its coverage with a Buy recommendation and a $7 target, citing the potential of its lead asset, vidofludimus calcium, designed to treat ...

Boeing, is higher by 7% year to date, with GE Vernova up an astounding 73% in that time. The IMF pared its global growth forecast for this year, but it is still above 3%. Plus, investment newsletter ...

Pulumi has announced that Bun is now a fully supported runtime for Pulumi, going beyond its previous role as merely a package ...

Technical analysis is a methodology used by traders and investors to make decisions about buying and selling financial assets, such as stocks, currencies, commodities, and cryptocurrencies. It ...

Sun et al. present a stem cell-derived embryo model recapitulating certain aspects of human peri-gastrulation, including the formation of trilaminar disc-, amnion- and yolk sac-like structures.

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Get personalized ...

A Unique College. A Superior Education. Learn more about our unmatched opportunities for deaf and hard-of-hearing students. Coming to RIT/NTID is about getting access to opportunities and people who ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best emerging technology stocks to invest in. On December 18, Guggenheim analyst Yatin Suneja raised the firm’s price target on ABIVAX to $175 from ...

Deciphering cellular microenvironments at atlas scale remains challenging. Here, authors present a scalable contrastive learning framework using cell-centric subgraphs to map niches across platforms.